Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1184169687
总结
TPMT *1/*3C is associated with increased risk of neutropenia and infections when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma.